Efficacy and Tolerability of Levetiracetam in central poststroke pain - a randomised, double blind, placebo controlled, cross-over study

Trial Profile

Efficacy and Tolerability of Levetiracetam in central poststroke pain - a randomised, double blind, placebo controlled, cross-over study

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Central pain; Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms LESS
  • Most Recent Events

    • 18 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top